Squarepoint Ops LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $4.46 Million - $4.91 Million	-9,700 Reduced 46.86%	11,000 $5.12 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $7.7 Million - $9.52 Million	19,600 Added 1781.82%	20,700 $9.7 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $448,459 - $490,688	1,100 New	1,100 $459,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $94,326 - $105,573	300 Added 27.27%	1,400 $492,000
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $311,553 - $355,410	1,100 New	1,100 $346,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $1.59 Million - $1.77 Million	-5,800 Reduced 87.88%	800 $232,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $1.55 Million - $1.93 Million	6,600 New	6,600 $1.86 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.